Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study

Autor: E. Franceschi, S. Minichillo, A. Mura, A. Tosoni, M. Mascarin, C. Tomasello, S. Bartolini, A. A. Brandes

Publikováno v: BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)

Abstract Background Medulloblastoma is extremely rare in adults. The role of chemotherapy for average-risk adult patients remains controversial. Surgery and radiotherapy provide a significant disease control and a good prognosis, but about 25% of ave

Externí odkaz: https://doaj.org/article/be335f43e6544eceb4c75fe88e61d478

Data on the stability of darunavir/cobicistat suspension after tablet manipulation

Autor: D. Zanon, A. Manca, A. De Nicolò, A. D'Avolio, U.M. Musazzi, F. Cilurzo, N. Maximova, C. Tomasello, P. Minghetti

Publikováno v: Data in Brief, Vol 30, Iss , Pp 105552- (2020)

The COVID-19 outbreak is now one of the most critical crises to manage for most of the national healthcare systems in the world. In the absence of authorised pharmacological treatments, many antiretrovirals, including darunavir/cobicistat fixed combi

Externí odkaz: https://doaj.org/article/4c734a47db8a4e33bdf45ab59bb275d6

DOP20 Genetic of vitamin D as predictor of response to adalimumab in Crohn’s Disease

Autor: C. Tomasello, Lorenzo Bertani, Jessica Cusato, Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Antonio D'Avolio, M. Mangia, S Dibetto, Marco Astegiano, Miriam Antonucci

Publikováno v: Journal of Crohn's and Colitis. 15:S058-S061

Background Personalised medicine is the direction towards are converging many efforts of experts in inflammatory bowel diseases (IBDs). The advent of biological drugs, with anti-TNF as first category, have revolutionized the managements of these pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8f7ad8a85c82ad56b6e2fcd7884f8e88
https://doi.org/10.1093/ecco-jcc/jjab073.059

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

Autor: G. Cavaletti, D.R. Cornblath, I.S.J. Merkies, T.J. Postma, E. Rossi, B. Frigeni, P. Alberti, J. Bruna, R. Velasco, A.A. Argyriou, H.P. Kalofonos, D. Psimaras, D. Ricard, A. Pace, E. Galiè, C. Briani, C. Dalla Torre, C.G. Faber, R.I. Lalisang, W. Boogerd, D. Brandsma, S. Koeppen, J. Hense, D. Storey, S. Kerrigan, A. Schenone, S. Fabbri, M.G. Valsecchi, A. Mazzeo, A. Pessino, A. Toscano, B. Brouwer, B. Piras, C. Dominguez Gonzalez, C. Tomasello, D. Binda, D. Cortinovis, E. Lindeck Pozza, E.K. Vanhoutte, F. Lanzani, F. Pastorelli, G. Altavilla, G. Granata, I. Ghignotti, J.J. Heimans, L. Mattavelli, L. Padua, L. Reni, M. Bakkers, M. Boogerd, M. Campagnolo, M. Cazzaniga, M. Eurelings, M. Leandri, M. Lucchetta, M. Penas Prado, M. Russo, M.L. Piatti, P. Bidoli, R. Grant, R. Plasmati, R.J. Meijer, S.G. Dorsey, S. Galimberti, W. Grisold

Publikováno v: Annals of Oncology, 24(2), 454-462. Oxford University Press
Annals of Oncology, 24(2), 454-462. Elsevier Ltd.
Cavaletti, G, Cornblath, D R, Merkies, I S J, Postma, T J, Rossi, E, Frigeni, B, Alberti, P, Bruna, J, Velasco, R, Argyriou, A A, Kalofonos, H P, Psimaras, D, Ricard, D, Pace, A, Galie, E, Briani, C, la Torre, C, Faber, C G, Lalisang, R I, Boogerd, W, Brandsma, D, Koeppen, S, Hense, J, Storey, D, Kerrigan, S, Schenone, A, Fabbri, S & Valsecchi, M G 2013, ' The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings ', Annals of Oncology, vol. 24, no. 2, pp. 454-462 . https://doi.org/10.1093/annonc/mds329

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting complication of cancer treatment. Thus far, the impact of CIPN has not been studied in a systematic clinimetric manner. The objective of the study was to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cedae0406e59f84a8143344bc4be68f2
https://doi.org/10.1093/annonc/mds329

Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy-induced peripheral neuropathy in adolescents: A preliminary study

Autor: Francesca Stoppa, Chiara Mennini, Rita Maria Pinto, Umberto Raucci, Elena Conicella, C Tomasello

Publikováno v: Pediatric Blood & Cancer. 65:e27064

PURPOSE Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of chemotherapy, in need of effective treatment. Preliminary data support the efficacy of scrambler therapy (ST), a noninvasive cutaneous electrostimulation device, in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5273a2b593e337c17472031ea080243
https://doi.org/10.1002/pbc.27064